SOURCE: Media Analytics Corporation

September 20, 2013 08:05 ET

Media Analytics Corporation Announces New Headquarters

HONG KONG, CHINA--(Marketwired - Sep 20, 2013) - Media Analytics Corporation (OTCBB: MEDA) (OTCQB: MEDA) (the "Company") has announced a new headquarters site: Suite 1802, 18/F, Chinachem Exchange Square, 1 Hoi Wan Street, Quarry Bay, Hong Kong, 852. Operations will be based out of the new site, effective immediately.

"The Company was founded in Hong Kong, and our programmers and servers are located in Hong Kong, so it makes sense from the perspective of employee costs and business overhead while we are doing our due diligence on finding a base for our U.S. offices," said Stephen Wong, president of the Company. "At a very basic level, it enables us to better serve our global customer base affordably. From a bigger picture perspective, a Hong Kong location also gives us proximity to our partner SMB, which developed the Klarity technology that is critical to our business model, and allows us to leverage that relationship for maximum effectiveness."

Innovation and technology are major drivers for economic growth within Hong Kong; which has gained recognition as a world-class, knowledge-based economy. Significant efforts are being made within the private, government, and educational sectors to support innovative companies such as Media Analytics.

About Media Analytics Corporation

Media Analytics Corporation's social media tools and solutions enable advertisers, publishers and agencies in the U.S. and U.K. markets to gather deep social intelligence, generate true engagement and simplify promotional management. The company's current offering, Klarity, is the most comprehensive and robust social analytics dashboard available. Klarity provides detailed comparative metrics from the widest range of social platforms, and provides the added uniqueness for Western marketers to gain insights into the social behavior of Asian consumers.

www.media-analytics.us

Safe Harbor Statement

This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future business development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned and should consult all of the information set forth herein, that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and specifically statements relating to growth of the Company. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with the marketing of the Company's product candidates and products, unproven pre-clinical and clinical development activities, regulatory oversight, the Company's ability to manage its capital resource issues, competition, and the other factors discussed in detail in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.

Contact Information